Literature DB >> 24626629

Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.

Cristina Aguilar1, Cecilia Aguilar1, Rebeca Lopez-Marure2, Alejandro Jiménez-Sánchez1, Leticia Rocha-Zavaleta1.   

Abstract

The cytokines erythropoietin (Epo) and stem cell factor (SCF), coupled with the cooperation between their receptors (EpoR and c-Kit), are essential components of normal physiological erythropoiesis. In earlier studies, we demonstrated the expression of c-Kit and EpoR in cervical cancer cells. It was identified that SCF is a survival factor, whereas Epo promotes cell proliferation. Cooperation between EpoR and SCF in cervical cancer has rarely been studied, despite the fact that cell migration and anchorage independent growth are considered initial steps in metastasis. Thus, the aim of this study was to analyse the effect of SCF and Epo alone, or in combination, on the migration and anchorage independent growth of two cervical cancer-derived cell lines. First, we demonstrated the expression of EpoR and c-Kit in the cell lines. Next, we evaluated anchorage independent growth, and identified that Epo and SCF produced a modest number of colonies, whereas the combination Epo/SCF induced a significantly higher number of colonies. Migration was then evaluated in Boyden chambers. Co-stimulation with Epo/SCF induced a significantly higher number of migrating cells than either cytokine alone. SCF-, Epo- and Epo/SCF-induced migration was inhibited by blocking phosphorylation of Janus kinase 2 (JAK2). Accordingly, western blot analysis demonstrated that the JAK2/signal transducer and activator of transcription-5 (STAT5) axis was activated in all cases. By contrast, inhibition of extracellular signal-related kinase (ERK) 1/2 abrogated migration induced by SCF and Epo/SCF only. Concurrently, Epo induced a modest, transient activation of ERK1/2, whereas SCF and Epo/SCF prompted a strong, sustained phosphorylation of ERK1/2. The results from this study have revealed that co-stimulation with Epo/SCF promotes migration and anchorage independent cell growth, and that co-signalling from EpoR and c-Kit converge on JAK2/STAT5 activation. Furthermore, SCF- and Epo/SCF-induced migration depends on the sustained activation of ERK1/2. These results indicate that co-signalling from different cytokine receptors induces migration, and this suggests that migratory behaviour may be regulated by the cooperative activity of Epo and SCF in cells expressing their cognate receptors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24626629     DOI: 10.3892/mmr.2014.2044

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  13 in total

1.  Human cervical cancer oncogene-1 over expression in colon cancer and its clinical significance.

Authors:  Kai Meng; Min Yuan; Shujian Xu; Lifeng Wang; Zhe Li; Mingyu Wang; Rong Ma
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.

Authors:  Asaf Madi; Sharron Bransburg-Zabary; Ayala Maayan-Metzger; Gittit Dar; Eshel Ben-Jacob; Irun R Cohen
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

3.  Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression.

Authors:  Valeria Cernaro; Alessandra Sfacteria; Claudia Rifici; Francesco Macrì; Giulia Maricchiolo; Antonio Lacquaniti; Carlo Alberto Ricciardi; Antoine Buemi; Giuseppe Costantino; Domenico Santoro; Michele Buemi
Journal:  J Nephrol       Date:  2016-09-27       Impact factor: 3.902

4.  Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.

Authors:  Li Wang; JianTao Wang; Zhixi Li; YanYang Liu; Ming Jiang; Yan Li; Dan Cao; Maoyuan Zhao; Feng Wang; Feng Luo
Journal:  Tumour Biol       Date:  2015-12-14

5.  Erythropoietin enhances migration of human neuroblastoma cells: in vitro studies and potential therapeutic implications.

Authors:  Agata Poniewierska-Baran; Justyna Rajewska-Majchrzak; Mariusz Z Ratajczak
Journal:  J Cancer Stem Cell Res       Date:  2017-04-27

Review 6.  Erythropoietin and cancer: the unintended consequences of anemia correction.

Authors:  Nataša Debeljak; Peter Solár; Arthur J Sytkowski
Journal:  Front Immunol       Date:  2014-11-11       Impact factor: 7.561

7.  MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit.

Authors:  Mingfen Lv; Rongying Ou; Qianwen Zhang; Fan Lin; Xiangyun Li; Keyu Wang; Yunsheng Xu
Journal:  Drug Des Devel Ther       Date:  2019-07-17       Impact factor: 4.162

8.  Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications.

Authors:  Agata Poniewierska-Baran; Malwina Suszynska; Wenyue Sun; Ahmed Abdelbaset-Ismail; Gabriela Schneider; Frederic G Barr; Mariusz Z Ratajczak
Journal:  Int J Oncol       Date:  2015-09-24       Impact factor: 5.650

9.  BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.

Authors:  Yuanyuan Li; Nan Cui; Peng-Sheng Zheng; Wen-Ting Yang
Journal:  Oncotarget       Date:  2017-07-25

10.  Endogenous erythropoietin signaling regulates migration and laminar positioning of upper-layer neurons in the developing neocortex.

Authors:  Paul E Constanthin; Alessandro Contestabile; Volodymyr Petrenko; Charles Quairiaux; Patrick Salmon; Petra S Hüppi; Jozsef Z Kiss
Journal:  Development       Date:  2020-10-07       Impact factor: 6.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.